These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
90 related items for PubMed ID: 19317293
21. An evaluation of data for 10 children born to mothers who attempted suicide by taking large doses of alprazolam during pregnancy. Gidai J, Acs N, Bánhidy F, Czeizel AE. Toxicol Ind Health; 2008; 24(1-2):53-60. PubMed ID: 18818181 [Abstract] [Full Text] [Related]
22. Application of the hypothesis of Developmental Origin of Health and Diseases (DOHaD) in epidemiological studies of women at reproductive age and pregnant women in Poland. Wojtyła A. Ann Agric Environ Med; 2011; 18(2):355-64. PubMed ID: 22216813 [Abstract] [Full Text] [Related]
23. The effects of benzodiazepines in pregnancy. Leppée M, Culig J, Eric M, Sijanovic S. Acta Neurol Belg; 2010 Jun; 110(2):163-7. PubMed ID: 20873446 [Abstract] [Full Text] [Related]
24. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors. Brent RL. Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188 [Abstract] [Full Text] [Related]
25. Nongenital malformations following exposure to progestational drugs: the last chapter of an erroneous allegation. Brent RL. Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):906-18. PubMed ID: 16206282 [Abstract] [Full Text] [Related]
26. [Prenatal exposure to birth control pills: risk of fetal death and congenital malformations]. Jellesen R, Andersen AM. Ugeskr Laeger; 2006 Jun 19; 168(25):2437-42. PubMed ID: 16824365 [Abstract] [Full Text] [Related]
27. Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors. Cooper WO. J Cardiovasc Nurs; 2008 Jun 19; 23(1):20-4. PubMed ID: 18158502 [Abstract] [Full Text] [Related]
28. Smallpox vaccination and adverse reactions. Guidance for clinicians. Cono J, Casey CG, Bell DM, Centers for Disease Control and Prevention. MMWR Recomm Rep; 2003 Feb 21; 52(RR-4):1-28. PubMed ID: 12617510 [Abstract] [Full Text] [Related]
29. Antiepileptic treatment in pregnant women: morphological and behavioural effects. Tomson T, Battino D. Handb Exp Pharmacol; 2011 Feb 21; 205():295-315. PubMed ID: 21882118 [Abstract] [Full Text] [Related]
30. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants. Williams PL, Crain MJ, Yildirim C, Hazra R, Van Dyke RB, Rich K, Read JS, Stuard E, Rathore M, Mendez HA, Watts DH, Pediatric HIV/AIDS Cohort Study. JAMA Pediatr; 2015 Jan 21; 169(1):48-55. PubMed ID: 25383770 [Abstract] [Full Text] [Related]
31. Position statement from the European Board and College of Obstetrics & Gynaecology (EBCOG): The use of medicines during pregnancy - call for action. Van Calsteren K, Gersak K, Sundseth H, Klingmann I, Dewulf L, Van Assche A, Mahmood T. Eur J Obstet Gynecol Reprod Biol; 2016 Jun 21; 201():189-91. PubMed ID: 27132709 [Abstract] [Full Text] [Related]
32. Fetal malformations associated with the use of methylphenobarbital and carbamazepine during pregnancy. Two case reports and review of the literature. Aksamija A, Habek D, Stanojević M, Ujević B. Fetal Diagn Ther; 2009 Jun 21; 25(1):79-82. PubMed ID: 19218807 [Abstract] [Full Text] [Related]
33. Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study. Nørgaard M, Pedersen L, Gislum M, Erichsen R, Søgaard KK, Schønheyder HC, Sørensen HT. J Antimicrob Chemother; 2008 Jul 21; 62(1):172-6. PubMed ID: 18400803 [Abstract] [Full Text] [Related]
34. [Cross-sectional study of drug use in pregnancy]. Culig J, Leppée M, Stimac D, Kuvacić I, Pulanić-Klepac T, Herman R, Tuckar N, Podobnik M, Klobucar A, Matesa S, Polić-Vizintin M, Damić AM. Lijec Vjesn; 2007 Jul 21; 129(8-9):253-9. PubMed ID: 18198623 [Abstract] [Full Text] [Related]
35. Early pregnancy exposure to feto-toxic medications among out-patients in Malawi. Kabuluzi E, Campbell M, McGowan L, Chirwa E, Brabin L. J Matern Fetal Neonatal Med; 2014 Aug 21; 27(12):1204-8. PubMed ID: 24168054 [Abstract] [Full Text] [Related]
36. The current state of therapeutic drug trials in pregnancy. Endicott S, Haas DM. Clin Pharmacol Ther; 2012 Aug 21; 92(2):149-50. PubMed ID: 22814658 [Abstract] [Full Text] [Related]
37. Foetal safety of old and new antiepileptic drugs. Verrotti A, Mencaroni E, Castagnino M, Zaccara G. Expert Opin Drug Saf; 2015 Oct 21; 14(10):1563-71. PubMed ID: 26329145 [Abstract] [Full Text] [Related]
38. Reproductive Safety of Second-Generation Antipsychotics: Current Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. Cohen LS, Viguera AC, McInerney KA, Freeman MP, Sosinsky AZ, Moustafa D, Marfurt SP, Kwiatkowski MA, Murphy SK, Farrell AM, Chitayat D, Hernández-Díaz S. Am J Psychiatry; 2016 Mar 01; 173(3):263-70. PubMed ID: 26441156 [Abstract] [Full Text] [Related]
39. Genetic health and prenatal diagnostics in clinical center Brcko District. Kolarski M, Krstic A, Nikić S, Joksic G, Umicevic G, Fatusic Z, Privrodski JJ, Petrović Z. Med Arh; 2009 Mar 01; 63(2):64-6. PubMed ID: 19537657 [Abstract] [Full Text] [Related]